Antinociception in rat by sarpogrelate, a selective 5-HT(2A) receptor antagonist, is peripheral

European Journal of Pharmacology

Volumn 404, Issue 1-2, 2000, Pages 95-102

  Obata, Hideaki ^a   Saito, Shigeru ^a   Ishizaki, Keiji ^a   Goto, Fumio ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

(Rat); 5 HT(2A) receptor antagonist; Antinociception; Formalin test; Sarpogrelate

Indexed keywords

SARPOGRELATE; SEROTONIN; SEROTONIN 2A RECEPTOR;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; FACILITATION; MALE; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

ANALGESICS; ANIMALS; MALE; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; REFLEX; SEROTONIN ANTAGONISTS; SUCCINATES;

EID: 0034666628     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00522-7     Document Type: Article

References (34)

1. 2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology. 35:1996;99-110.
2. 2A receptors. Neuroscience. 77:1997;575-584.
3. 2 receptors in nociceptive transmission. Brain Res. 543:1991;335-340.
4. Armstrong D., Dry R.M.L., Keele C.A., Markham J.W. Observations on chemical excitants of cutaneous pain in man. J. Physiol. 120:1953;326-351.
5. 2 antagonist ritanserin in rats: evidence for an activation of descending monoaminergic pathways in the spinal cord. Neurosci. Lett. 99:1989;234-238.
6. Bardin L., Bardin M., Lavarenne L., Eschalier A. Effect of intrathecal serotonin on nociception in rats: influence of the pain test used. Exp. Brain Res. 113:1997;81-87.
7. 2A receptors in peripheral sensory axons in rat glabrous skin. Brain Res. 763:1997;271-275.
8. 3 receptor subtypes modulate responses to noxious colorectal distension in the rat. Brain Res. 538:1991;64-75.
9. 2 serotonergic antagonists, on the secondary recruitment of human platelets in vitro. Agents Actions. 17:1985;515-526.
10. 2 receptors. Eur. J. Pharmacol. 154:1988;285-291.
11. 2-serotonergic receptor antagonist. Thromb. Haemostasis. 65:1991;415-420.
12. Hong Y., Abbott F.V. Behavioural effects of intaplantar injection of inflammatory mediators in the rat. Neuroscience. 63:1994;827-836.
13. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharm. Rev. 46:1994;157-203.
14. Hwang J.H., Hwang K.S., Leem J.K., Park P.H., Han S.M., Lee D.M. The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain. Anesthesiology. 90:1999;492-499.
15. Kikumoto R., Hara H., Ninomiya K., Osakabe M., Sugano M., Fukami H., Tamao Y. Synthesis and platelet aggregation inhibitory and antithrombotic properties of [2[(ω-aminoalkoxy)pheny]ethyl]benzens. J. Med. Chem. 33:1990;1818-1823.
16. Leger L., Descarries L. Serotonin nerve terminals in the locus coeruleus of adult rat: a radioautographic study. Brain Res. 145:1978;1-13.
17. Malmberg A.B., Fallgren B., Hedner T. Antinociceptive effect of α-trinositol, a novel D-myo-inositol phosphate derivative, in the formalin test in rats. Eur. J. Pharmacol. 294:1995;609-615.
18. Maruyama K., Kinami J., Sugita Y., Takada Y., Sugiyama E., Thuchihashi H., Nagatomo T. MCI-9042: high affinity for serotonergic receptors as assessed by radioligand binding assay. J. Pharmacobio-Dyn. 14:1991;177-181.
19. McRae-Degueurce A., Dennis T., Leger L., Scatton B. Regulation of noradrenergic neuronal activity in the rat locus coeruleus by serotoninergic afferents. Physiol. Psychol. 13:1985;188-196.
20. Nishio H., Inoue A., Nakata Y. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor sybtypes. Arch. Int. Pharmacodyn. Ther. 331:1996;189-202.
21. Otake T., Ieshima H., Ishida H., Ushigome Y., Saito S. Bone atrophy in complex regional pain syndrome patients measured by microdensitometry. Can. J. Anaesth. 45:1998;831-838.
22. Page C.P. Platelets as inflammatory cells. Immunopharmacology. 17:1989;51-59.
23. 2A receptor specificity, stereoselectivity and modulation of ritanserin-induced depression of 5-HT contraction in rat tail artery. J. Pharm. Pharmacol. 47:1995;310-316.
24. Ramabadran K., Bansinath M. A critical analysis of the experimental evaluation of nociceptive reactions in animals. Pharm. Res. 3:1986;263-270.
25. 2 antagonists. Brain Res. 385:1986;395-400.
26. Schmauss C., Hammond D.L., Ochi J.W., Yaksh T.L. Pharmacological antagonism of the antinociceptive effects of serotonin in the rat spinal cord. Eur. J. Pharmacol. 90:1983;349-357.
27. Schmelz M., Osiander G., Blunk J., Ringkamp M., Reeh P.W., Handwerker H.O. Intracutaneous injection of platelets cause acute pain and protracted hyperalgesia. Neurosci. Lett. 226:1997;171-174.
28. Segal M. Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J. Physiol. 286:1979;401-415.
29. Solomon R.E., Gebhart G.F. Mechanisms of effects of intrathecal serotonin on nociception and blood pressure in rats. J. Pharmacol. Exp. Ther. 245:1988;905-912.
30. Sufka K.J., Schomburg F.M., Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol. Biochem. Behav. 41:1992;53-56.
31. 2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain. 76:1998;349-355.
32. Yaksh T.L., Rudy T.A. Chronic catheterzation of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.
33. Yaksh T.L., Wilson T.R. Spinal serotonin terminal system mediates antinociception. J. Pharmacol. Exp. Ther. 208:1979;446-453.
34. Yamamoto T., Yaksh T.L. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology. 77:1992;757-763.